Status:
RECRUITING
Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
CAR-T Cell Therapy
Extracellular Vesicles
Eligibility:
All Genders
18-90 years
Brief Summary
Patients with refractory/relapse hematologic oncology disease may benefit from innovative therapy such as Car-T cells. Factors strongly predictive of outcome and response are unknown. Extracellular ve...
Eligibility Criteria
Inclusion
- patients affeccted by any hematological malignancies (r/r B cell lymphoma, B cell acute leukemia and multiple myeloma) undergoing (or whit indication to) CAR-T cell infusion with a CAR-T cell product;
- age: 18 years or greater;
- obtained written consent to the study participation.
Exclusion
- none
Key Trial Info
Start Date :
August 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06554951
Start Date
August 31 2024
End Date
August 31 2026
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138